Abstract
Leprosy is a chronic infectious disease caused by Mycobacterium leprae. Previous studies have demonstrated that the difference among clinical forms of leprosy can be associated with the immune response of patients, mainly by T helper (Th) and regulatory T cells (Tregs). Then, aiming at clarifying the immune response, the expression of cytokines related to Th1, Th2, Th17 and Tregs profiles were evaluated by qPCR in 87 skin biopsies from leprosy patients. Additionally, cytokines and anti-PGL-1 antibodies were determined in serum by ELISA. The results showed that the expression of various targets (mRNA) related to Th1, Th2, Th17 and Tregs were significantly modulated in leprosy when compared with healthy individuals, suggesting the presence of a mixed profile. In addition, the targets related to Th1 predominated in the tuberculoid pole and side and Th2 and Tregs predominated in the lepromatous pole and side; however, Th17 targets showed a mixed profile. Concerning reactional events, Tregs markers were decreased and IL-15 was increased in reversal reaction and IL-17F, CCL20 and IL-8 in erythema nodosum leprosum, when compared with the respective non-reactional leprosy patients. Additionally, ELISA analysis demonstrated that IL-22, IL-6, IL-10 and anti-PGL-1 antibody levels were significantly higher in the serum of patients when compared with healthy individuals, and IL-10 and anti-PGL-1 antibodies were also increased in the lepromatous pole and side. Together, these results indicate that Th1, Th2 and Th17 are involved in the determination of clinical forms of leprosy and suggest that decreased Tregs activity may be involved in the pathogenesis of reactional events.
Similar content being viewed by others
References
Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL (2006) The continuing challenges of leprosy. Clin Microbiol Rev 19:338–381
World Health Organization (2015) Global leprosy update 2015: time for action, accountability and inclusion. Wkly Epidemiol Rec 91:405–420
Bratschi MW, Steinmann P, Wickenden A, Gillis TP (2015) Current knowledge on Mycobacterium leprae transmission: a systematic literature review. Lepr Rev 86:142–155
Ridley DS, Jopling WH (1966) Classification of leprosy according to immunity. a five-group system. Int J Lepr Other Mycobact Dis 34:255–273
Yamamura M, Wang XH, Ohmen JD, Uyemura K, Rea TH, Bloom BR, Modlin RL (1992) Cytokine patterns of immunologically mediated tissue damage. J Immunol 149:1470–1475
Sieling PA, Modlin RL (1994) Cytokine patterns at the site of mycobacterial infection. Immunobiology 191:378–387
Sieling PA, Wang XH, Gately MK, Oliveros JL, McHugh T, Barnes PF, Wolf SF, Golkar L, Yamamura M, Yogi Y, Uyemura K, Rea TH, Modlin RL (1994) IL-12 regulates T helper type 1 cytokine responses in human infectious disease. J Immunol 153:639–3647
Misra N, Murtaza A, Walker B, Narayan NP, Misra RS, Ramesh V, Singh S, Colston MJ, Nath I (1995) Cytokine profile of circulating T cells of leprosy patients reflects both indiscriminate and polarized T-helper subsets: T-helper phenotype is stable and uninfluenced by related antigens of Mycobacterium leprae. Immunology 86:97–103
Nath I, Saini C, Valluri VL (2015) Immunology of leprosy and diagnostic challenges. Clin Dermatol 33:90–98. doi:10.1016/j.clindermatol.2014.07.005
de Souza VN, Iyer AM, Lammas DA, Naafs B, Das PK (2016) Advances in leprosy immunology and the field application: a gap to bridge. Clin Dermatol 34:82–95. doi:10.1016/j.clindermatol.2015.10.013
Fonseca AB, Simon MD, Cazzaniga RA, de Moura TR, de Almeida RP, Duthie MS, Reed SG, de Jesus AR (2017) The influence of innate and adaptative immune responses on the differential clinical outcomes of leprosy. Infect Dis Poverty 6:5. doi:10.1186/s40249-016-0229-3
Saini C, Tarique M, Rai R, Siddiqui A, Khanna N, Sharma A (2017) T helper cells in leprosy: an update. Immunol Lett 184:61–66. doi:10.1016/j.imlet.2017.02.013
Campbell DJ, Koch MA (2011) Phenotypical and functional specialization of FOXP3 + regulatory T cells. Nat Rev Immunol 11:119–130. doi:10.1038/nri2916
Modlin RL, Kato H, Mehra V, Nelson EE, Fan XD, Rea TH, Pattengale PK, Bloom BR (1986) Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Nature 322:459–461
Ottenhoff TH, Haanen JB, Geluk A, Mutis T, Ab BK, Thole JE, van Schooten WC, van den Elsen PJ, de Vries RR (1991) Regulation of mycobacterial heat-shock protein-reactive T cells by HLA class II molecules: lessons from leprosy. Immunol Rev 121:171–191
Mutis T, Cornelisse YE, Datema G, van den Elsen PJ, Ottenhoff TH, de Vries RR (1994) Definition of a human suppressor T-cell epitope. Proc Natl Acad Sci USA 91:9456–9460
Misra N, Selvakumar M, Singh S, Bharadwaj M, Ramesh V, Misra RS, Nath I (1995) Monocyte derived IL 10 and PGE2 are associated with the absence of Th 1 cells and in vitro T cell suppression in lepromatous leprosy. Immunol Lett 48:123–128
Fernandes C, Gonçalves HS, Cabral PB, Pinto HC, Pinto MI, Câmara LM (2013) Increased frequency of CD4 and CD8 regulatory T cells in individuals under 15 years with multibacillary leprosy. PLoS ONE 8:e79072. doi:10.1371/journal.pone.0079072
Bobosha K, Wilson L, van Meijgaarden KE, Bekele Y, Zewdie M, van der Ploeg-van Schip JJ, Abebe M, Hussein J, Khadge S, Neupane KD, Hagge DA, Jordanova ES, Aseffa A, Ottenhoff TH, Geluk A (2014) T-cell regulation in lepromatous leprosy. PLoS Negl Trop Dis 8:e2773. doi:10.1371/journal.pntd.0002773
Saini C, Ramesh V, Nath I (2014) Increase in TGF-β secreting CD4+CD25+ FOXP3+ T regulatory cells in anergic lepromatous leprosy patients. PLoS Negl Trop Dis 8:e2639. doi:10.1371/journal.pntd.0002639
Sadhu S, Khaitan BK, Joshi B, Sengupta U, Nautival AK, Mitra DK (2016) Reciprocity between regulatory T Cells and Th17 Cells: relevance to polarized immunity in leprosy. PLoS Negl Trop Dis 10:e0004338. doi:10.1371/journal.pntd.0004338
Geluk A (2013) Challenges in immunodiagnostic tests for leprosy. Expert Opin Med Diagn 7:265–274. doi:10.1517/17530059.2013.786039
Torchinsky MB, Blander JM (2010) T helper 17 cells: discovery, function, and physiological trigger. Cell Mol Life Sci 67:1407–1421. doi:10.1007/s00018-009-0248-3
Saini C, Ramesh V, Nath I (2013) CD4+ Th17 cells discriminate clinical types and constitute a third subset of non Th1, non Th2 T cells in human leprosy. PLoS Negl Trop Dis 7:e2338. doi:10.1371/journal.pntd.0002338
Chaitanya S, Lavania M, Turankar RP, Karri SR, Sengupta U (2012) Increased serum circulatory levels of interleukin 17F in type 1 reactions of leprosy. J Clin Immunol 32:1415–1420. doi:10.1007/s10875-012-9747-3
Martiniuk F, Giovinazzo J, Tan AU, Shahidullah R, Haslett P, Kaplan G, Levis WR (2012) Lessons of leprosy: the emergence of Th17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity. J Drugs Dermatol 11:626–630
Garlet GP, Horwat R, Ray HL Jr, Garlet TP, Silveira EM, Campanelli AP, Trombone AP, Letra A, Silva RM (2012) Expression analysis of wound healing genes in human periapical granulomas of progressive and stable nature. J Endod 38:185–190. doi:10.1016/j.joen.2011.09.011
Brett SJ, Payne SN, Gigg J, Burgess P, Gigg R (1986) Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid-I in the serology of leprosy. Clin Exp Immunol 64:476–483
Modlin RL (1994) Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 102:828–832
Modlin RL (2002) Learning from leprosy: insights into contemporary immunology from an ancient disease. Skin Pharmacol Appl Skin Physiol 15:1–6
Wolk K, Witte E, Witte K, Warszawska K, Sabat R (2010) Biology of interleukin-22. Semin Immunopathol 32:17–31. doi:10.1007/s00281-009-0188-x
Akdis M, Palomares O, van de Veen W, van Splunter M, Akdis CA (2012) TH17 and TH22 cells: a confusion of antimicrobial response with tissue inflammation versus protection. J Allergy Clin Immunol 129:1438–1449. doi:10.1016/j.jaci.2012.05.003
de Lima Silveira E, de Sousa JR, de Sousa Aarão TL, Fuzii HT, Dias Junior LB, Carneiro FR, Quaresma JÁ (2015) New immunologic pathways in the pathogenesis of leprosy: role for Th22 cytokines in the polar forms of the disease. J Am Acad Dermatol 72:729–730. doi:10.1016/j.jaad.2014.11.023
Attia EA, Abdallah M, El-Khateeb E, Saad AA, Lotfi RA, Abdallah M, El-Shennawy D (2014) Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines. Arch Dermatol Res 306:793–801. doi:10.1007/s00403-014-1486-2
Saini C, Siddiqui A, Ramesh V, Nath I (2016) Leprosy reactions show increased Th17 cell activity and reduced FOXP3+ Tregs with concomitant decrease in TGF-β and increase in IL-6. PLoS Negl Trop Dis 10:e0004592. doi:10.1371/journal.pntd.0004592
Jabri B, Abadie V (2015) IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction. Nat Rev Immunol 15:771–783. doi:10.1038/nri3919
Patidar M, Yadav N, Dalai SK (2016) Interleukin 15: a key cytokine for immunotherapy. Cytokine Growth Factor Rev 31:49–59. doi:10.1016/j.cytogfr.2016.06.001
Montoya D, Inkeles MS, Liu PT, Realegeno S, Teles RM, Vaidya P, Munoz MA, Schenk M, Swindell WR, Chun R, Zavala K, Hewison M, Adams JS, Horvath S, Pellegrini M, Bloom BR, Modlin RL (2014) IL-32 is a molecular marker of a host defense network in human tuberculosis. Sci Transl Med 6(250):250ra114. doi:10.1126/scitranslmed.3009546
Bloom BR, Modlin RL (2016) Mechanisms of defense against intracellular pathogens mediated by human macrophages. Microbiol Spectr. doi:10.1128/microbiolspec
Fachin LR, Soares CT, Belone AF, Trombone AP, Rosa PS, Guidella CC, Franco MF (2017) Immunohistochemical assessment of cell populations in leprosy-spectrum lesions and reactional forms. Histol Histopathol 32:385–396. doi:10.14670/HH-11-804
Vieira AP, Trindade MA, Pagliari C, Avancini J, Sakai-Valente NY, Duarte AJ, Benard G (2016) Development of type 2, but not type 1, leprosy reactions is associated with a severe reduction of circulating and in situ regulatory T-cells. Am J Trop Med Hyg 94:721–727. doi:10.4269/ajtmh.15-0673
Kahawita IP, Lockwood DN (2008) Towards understanding the pathology of erythema nodosum leprosum. Trans R Soc Trop Med Hyg 102:329–337. doi:10.1016/j.trstmh.2008.01.004
Santos MB, de Oliveira DT, Cazzaniga RA, Varjão CS, Santos PLD, Santos MLB, Correia CB, Faria DR, Simon MDV, Silva JS, Dutra WO, Reed SG, Duthie MS, de Almeida RP, de Jesus AR (2017) Distinct roles of Th17 and Th1 cells in inflammatory responses associated with the presentation of paucibacillary leprosy and leprosy reactions Th17 immune response in leprosy. Scand J Immunol. doi:10.1111/sji.12558
Acknowledgements
This study was supported by Grants from Fundação de Amparo à Pesquisa do Estado de São Paulo—FAPESP (2009/06122-5).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Azevedo, M.d.S., Marques, H., Binelli, L.S. et al. Simultaneous analysis of multiple T helper subsets in leprosy reveals distinct patterns of Th1, Th2, Th17 and Tregs markers expression in clinical forms and reactional events. Med Microbiol Immunol 206, 429–439 (2017). https://doi.org/10.1007/s00430-017-0519-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-017-0519-9